Let’s Connect

We appreciate you taking the time to learn a little more about why we are so passionate about creating a more inclusive healthcare landscape for patients and healthcare professionals. If our mission speaks to you, we’d love to connect!

Email:

info@mdnewsline.com

"*" indicates required fields

More Medical News
pexels-kampus-7551646
Cardiovascular Disease
Cardiovascular Risk Management

Noninvasive Imaging Aids Selection of Stenosis Patients Needing Revascularization Procedure

pexels-anntarazevich-8016903No increased risk for thyroid cancer seen with use of GLP1 receptor agonist versus DPP4 inhibitor use, SGLT2 inhibitor use
Oncology
Thyroid Cancer

GLP1 Receptor Agonist Use Does Not Seem to Increase Risk for Thyroid Cancer

pexels-kamaji-ogino-5094381Increased risk for all-cause mortality seen with postpartum young-onset breast cancer in women with germline BRCA pathogenic variants
Breast Cancer
OBGYN & Women's Health
Oncology

Mortality Up for Breast Cancer Diagnosed Five to <10 Years After Childbirth

pexels-cottonbro-4783542Achievement of ≥75 percent reduction in Psoriasis Area and Severity Index lower in both current, former smokers
Dermatology
Lifestyle
Psoriasis

Tobacco Smoking Reduces the Odds of Psoriasis Improvement

pexels-shvetsa-4586989A retrospective analysis finds that patients who undergo pneumonectomy or are aged 70 years or older after receiving neoadjuvant concurrent chemoradiation therapy experience less favorable surgical outcomes.
Non-Small Cell Lung Cancer
Oncology
Pulmonology

Risk Stratification in Post-Surgery Non-Small Cell Lung Cancer Patients

pexels-stephentcandrews-9765437Neoadjuvant chemoimmunotherapy, whether compared to immunotherapy alone or in combination with apatinib, may lead to increased surgical complexity while maintaining an acceptable incidence of postoperative complications, according to the results of a retrospective study.
Non-Small Cell Lung Cancer
Oncology
Pulmonology

Postoperative Complications and Surgical Issues With Neoadjuvant Immunotherapy-Treated Lung Cancer

Name

By subscribing, you agree to share your email address to receive our newsletter, events, and other updates. Please see our Privacy Policy and Terms of Service for more information. you can opt-out at any time

This field is for validation purposes and should be left unchanged.

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.